(trans,trans)-4'-Propyl-[1,1'-bi(cyclohexan)]-4-ol, 95.0%, 10g

1-(5-Bromo-2-fluorophenyl)ethan-1-amine, 98%, 250mg

1-(Pyrimidin-2-yl)pyrrolidin-3-amine dihydrochloride, 98+%, 1g

Flupyrimin, 98.69%, 100mg

Microliter syringe GASTIGHT® series 1700 Point type 3, 250 µl, 1725 RNR, 1 piece

(4-Methylbenzyl)hydrazine dihydrochloride, 95%, 5g

6-tert-Butyl-nicotinonitrile, 95.0%, 5g

2-{[(butan-2-yl)amino]methyl}-6-ethoxyphenol, 95.0%, 1g

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinoline-1(2H)-carboxylate, 97.0%, 250mg

Bis(phenylsulfonyl)methane, 96.0%, 100g

3-Methoxybenzhydrol, 97.0%, 25g

(R)-Quinuclidin-3-amine hydrochloride, 95.0%, 250mg

1,2-Phenylenediamine [for Biochemical Research]>98.0%(GC)(T)5g